Al-Wakeel Yasir B.
Transaction: 06/17/2026
BUY
Change
+49,579
Price
$1.13
Filing
06/22/2026
Type
BUY
MaxCyte, Inc.
MXCT • Biotechnology
$1.28
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$136.73M
Growth
7.8%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.1Healthy liquidity · 8.3Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:23 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.28
Change0.00%
Shares Out106.82M
Market Cap$136.73M
Enterprise Value$138.94M
52W Range0.64 - 1.86
Beta1.49
P/E-3.84
P/S4.40
P/B0.86
P/FCF-5.78
EV/Sales4.47
Price$1.28
Change0.00%
Shares Out106.82M
Market Cap$136.73M
Enterprise Value$138.94M
52W Range0.64 - 1.86
Beta1.49
P/E-3.84
P/S4.40
P/B0.86
P/FCF-5.78
EV/Sales4.47
EV/EBITDA-4.28
EV/FCF-5.88
Earnings Yield-26.06%
FCF Yield-17.29%
Dividend Yield0.00%
Gross Margin81.16%
Oper. Margin-137.12%
Profit Margin-135.14%
Debt/Eq0.10
Current Ratio8.30
Quick Ratio7.77
Revenue 5Y7.84%
Target$6.00
Target Upside368.75%
Target Median$6.00
Target Range6.00 - 6.00
Volume3.80M
Avg Volume1.08M
EPS Surprise0.06
Investment DNA
How strong this company looks for long-term investors
39
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
78/100
Why this score▼
Manageable debt level · 0.1Healthy liquidity · 8.3Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 6 analyst votes · 2026-09-04
83/100
Bullish
Bullish
4
Hold
2
Bearish
0
Price Target
2026-08-14
Low
$6.00
Mean
$6.00
Median
$6.00
High
$6.00
Insider Transactions
Recent executive and insider activity
Al-Wakeel Yasir B.
Transaction: 06/17/2026
BUY
Change
+30,421
Price
Not reported
Filing
06/22/2026
Type
BUY
BALTHROP PATRICK J
Transaction: 06/17/2026
BUY
Change
+49,579
Price
$1.13
Filing
06/22/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Al-Wakeel Yasir B. | BUY | +49,579 | $1.13 | 06/17/2026 | 06/22/2026 |
| Al-Wakeel Yasir B. | BUY | +30,421 | Not reported | 06/17/2026 | 06/22/2026 |
| BALTHROP PATRICK J | BUY | +49,579 | $1.13 | 06/17/2026 | 06/22/2026 |
| BALTHROP PATRICK J | BUY | +30,421 | Not reported | 06/17/2026 | 06/22/2026 |
| Brooke William W | BUY | +49,579 | $1.13 | 06/17/2026 | 06/22/2026 |
| Brooke William W | BUY | +30,421 | Not reported | 06/17/2026 | 06/22/2026 |
| Collins Cynthia | BUY | +49,579 | $1.13 | 06/17/2026 | 06/22/2026 |
| Collins Cynthia | BUY | +30,421 | Not reported | 06/17/2026 | 06/22/2026 |
| DOUGLAS RICHARD | BUY | +49,579 | $1.13 | 06/17/2026 | 06/22/2026 |
| DOUGLAS RICHARD | BUY | +30,421 | Not reported | 06/17/2026 | 06/22/2026 |
| Erck Stanley C | BUY | +49,579 | $1.13 | 06/17/2026 | 06/22/2026 |
| Erck Stanley C | BUY | +30,421 | Not reported | 06/17/2026 | 06/22/2026 |
| Hemrajani Rekha | BUY | +49,579 | $1.13 | 06/17/2026 | 06/22/2026 |
| Hemrajani Rekha | BUY | +30,421 | Not reported | 06/17/2026 | 06/22/2026 |
| Johnston John Joseph | BUY | +49,579 | $1.13 | 06/17/2026 | 06/22/2026 |
| Johnston John Joseph | BUY | +30,421 | Not reported | 06/17/2026 | 06/22/2026 |
| Ahuja Parmeet | BUY | +187,500 | Not reported | 04/15/2026 | 04/17/2026 |
| Ahuja Parmeet | OTHER | 0 | Not reported | 03/30/2026 | 04/10/2026 |
| Ahuja Parmeet | BUY | +375,000 | $0.68 | 03/30/2026 | 04/10/2026 |
| Masoud Maher | BUY | +300,000 | Not reported | 03/27/2026 | 03/31/2026 |